Indapamide SR/Amlodipine versus Valsartan/Amlodipine in hypertension
Research type
Research Study
Full title
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment with conditional titration based on the blood pressure control, in patients with uncontrolled essential hypertension after 1 month of Amlodipine 5 mg run-in treatment. An international, randomized, double-blind, multicenter controlled study.
IRAS ID
129870
Contact name
Rhian M Touyz
Contact email
Sponsor organisation
Institut de Recherches Internationales Servier
Eudract number
2012-001690-84
REC name
West of Scotland REC 1
REC reference
13/WS/0196
Date of REC Opinion
22 Aug 2013
REC opinion
Further Information Favourable Opinion